Lovastatin/Lisinopril/Aspirin

洛伐他汀/赖诺普利/阿司匹林

Report date: 2025/07/18 17:32:47

Base Information

Drug NameLovastatin/Lisinopril/Aspirin
Drug Alias NameAspirin/lisinopril/lovastatinpolypill-CardioPharmaCardiaPillCP-101(Cardiopharma)
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitorsAngiotensin-converting enzyme inhibitors
TargetsAngiotensin-converting enzymeHMG-CoA reductaseCyclooxygenases
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes LovastatinLisinoprilAspirin
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCardiopharma
China Registration ClassN/A

Develop Information

Active CompaniesCardiopharma
Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A